Literature DB >> 25097071

A randomized trial of intravenous glutamine supplementation in trauma ICU patients: response to the comments by Ozcelik et al.

Jon Pérez-Bárcena1, Abelardo García-de-Lorenzo, Antonio Buño, Juan A Llompart-Pou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25097071     DOI： 10.1007/s00134-014-3420-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Comments on Pérez-Bárcena et al.: a randomized trial of intravenous glutamine supplementation in trauma ICU patients.

Authors:  Zerrin Ozcelik; Yucel Gultekin; Seda Banu Akinci
Journal:  Intensive Care Med       Date:  2014-08-06       Impact factor: 17.440

2.  A randomized trial of intravenous glutamine supplementation in trauma ICU patients.

Authors:  Jon Pérez-Bárcena; Pedro Marsé; Arturo Zabalegui-Pérez; Esther Corral; Rubén Herrán-Monge; María Gero-Escapa; Mercedes Cervera; Juan Antonio Llompart-Pou; Ignacio Ayestarán; Joan Maria Raurich; Antonio Oliver; Antonio Buño; Abelardo García de Lorenzo; Guiem Frontera
Journal:  Intensive Care Med       Date:  2014-02-21       Impact factor: 17.440

3.  A randomized trial of glutamine and antioxidants in critically ill patients.

Authors:  Daren Heyland; John Muscedere; Paul E Wischmeyer; Deborah Cook; Gwynne Jones; Martin Albert; Gunnar Elke; Mette M Berger; Andrew G Day
Journal:  N Engl J Med       Date:  2013-04-18       Impact factor: 91.245

4.  The 2007 ESPEN Sir David Cuthbertson Lecture: amino acids between and within organs. The glutamate-glutamine-citrulline-arginine pathway.

Authors:  Nicolaas E P Deutz
Journal:  Clin Nutr       Date:  2008-05-23       Impact factor: 7.324

Review 5.  Glutamine supplementation to critically ill patients?

Authors:  Jan Wernerman
Journal:  Crit Care       Date:  2014-03-18       Impact factor: 9.097
  5 in total
  1 in total

1.  Prevalence of glutamine deficiency in ICU patients: a cross-sectional analytical study.

Authors:  Arista Nienaber; Robin Claire Dolman; Averalda Eldorine van Graan; Renee Blaauw
Journal:  Nutr J       Date:  2016-08-02       Impact factor: 3.271
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.